Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute, Egypt
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Acepodia Biotech, Inc.
SCG Cell Therapy Pte. Ltd.
Brooklyn ImmunoTherapeutics, LLC
NexImmune Inc.
Dana-Farber Cancer Institute
Fate Therapeutics
Fate Therapeutics
Corregene Biotechnology Co., Ltd
Mie University
Brooklyn ImmunoTherapeutics, LLC
Gruppo Oncologico del Nord-Ovest
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mie University
National Cancer Institute (NCI)
Herlev Hospital
University of Yamanashi